Want to see JP:9987 full AI Analyst Report?

Suzuken Co (9987) Price & Analysis

0 Followers

9987 Stock Chart & Stats

¥5148.00

¥34.00(0.65%)

At close: Jul 28 4:00 PM EDT

¥5148.00

¥34.00(0.65%)

Day’s Range― - ―

52-Week Range¥2,385.00 - ¥3,334.00

Previous CloseN/A

Volume172.10K

Average Volume (3M)336.31K

Market Cap

¥335.22B

Enterprise Value¥209.64B

Total Cash (Recent Filing)¥148.78B

Total Debt (Recent Filing)¥24.38B

Price to Earnings (P/E)9.6

Beta0.44

Next Earnings

Nov 06, 2026

EPS Estimate

43.13

Next Dividend Ex-DateN/A

Dividend Yield4.23%

Share Statistics

EPS (TTM)271.45

Shares Outstanding144,334,410

10 Day Avg. Volume366,580

30 Day Avg. Volume336,306

Financial Highlights & Ratios

PEG Ratio0.54

Price to Book (P/B)1.00

Price to Sales (P/S)0.17

P/FCF Ratio22.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥6,250.00

Price Target Upside21.41% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)182.88

Revenue Forecast (FY)¥2.57T

Bulls Say, Bears Say

Bulls Say

Very Conservative Balance SheetSuzuken’s near-zero leverage and zero debt in 2026 reduce financing pressure and preserve flexibility during weaker operating periods. A large, stable equity base also supports continued investment in distribution capabilities, customer relationships, and healthcare services without relying heavily on external borrowing.

Steady Revenue And Profit GrowthSteady revenue growth indicates continued demand across Suzuken’s healthcare distribution relationships, while stronger net income shows that expansion has translated into improved earnings. This combination can support internal reinvestment and strengthen the company’s earnings base over the next several quarters.

Improving Profitability And ReturnsImproving margins and higher returns on equity suggest Suzuken is using its established capital base more effectively than in earlier years. Even though the distribution model remains low margin, this trend supports better operating quality and provides a foundation for more durable earnings generation.

Bears Say

Volatile Cash ConversionLarge year-to-year swings in operating and free cash flow reduce confidence that accounting profits will consistently convert into cash. Working-capital movements can materially affect liquidity, potentially limiting the timing of reinvestment, shareholder distributions, or other capital allocation decisions.

Structurally Thin MarginsThin margins leave limited room to absorb operating inefficiencies or unfavorable changes in product mix while maintaining profitability. Because earnings are generated on relatively modest spreads, sustained returns depend on scale, cost discipline, and efficient execution across the distribution network.

Recent EBIT PressureA decline in EBIT alongside continued revenue growth indicates that incremental sales did not fully translate into operating profit in 2026. If cost pressure persists, it could slow the recent profitability improvement and make earnings growth more dependent on revenue expansion rather than operating leverage.

Suzuken Co News

Suzuken Advances Share Buyback Ahead of Two-for-One Stock Split

Suzuken Co ( ($JP:9987) ) just unveiled an update. Suzuken Co., Ltd. has reported that it repurchased 990,000...

12d ago

Suzuken Sees Silchester Lift Stake to Become Largest Shareholder

Suzuken Co ( ($JP:9987) ) has shared an announcement. Suzuken Co. has announced a change in its major...

1M ago

Suzuken Advances Capital Policy With Share Buyback Ahead of Stock Split

Suzuken Co ( ($JP:9987) ) has provided an announcement. Suzuken Co. has executed a share repurchase of 990,000...

1M ago

Suzuken Sets ToSTNeT-3 Buyback as Part of Expanded Share Repurchase and Stock Split Plan

Suzuken Co ( ($JP:9987) ) has issued an update. Suzuken Co., Ltd. has approved a specific method to...

1M ago

Suzuken Launches ¥18 Billion Share Buyback Ahead of Stock Split

Suzuken Co ( ($JP:9987) ) has shared an announcement. Suzuken Co., Ltd. has authorized a new share repurchase...

2M ago

Suzuken Targets October Restart for Quake-Hit SKK Kumamoto Plant, Sees Limited Group Earnings Impact

Suzuken Co ( ($JP:9987) ) has provided an announcement. Suzuken said its subsidiary Sanwa Kagaku Kenkyusho’s Kumamoto Plant,...

2M ago

Suzuken Posts Higher Sales but Profit Decline, Affirms Outlook and Stock Split Plan

Suzuken Co ( ($JP:9987) ) has shared an update. Suzuken reported consolidated net sales of ¥628.9 billion for...

2M ago

SZUKF Earnings this Week: How Will it Perform?

Suzuken Co (SZUKF) is scheduled to report 1st quarter earnings on 08/07/2026. Regarding Q1 estimates, Wall Street analysts...

2M ago

Suzuken Assesses Kumamoto Quake Impact as Kumamoto Plant Halts Operations

Suzuken Co ( ($JP:9987) ) just unveiled an announcement. Suzuken has activated emergency response headquarters across its group...

2M ago

Suzuken to Grant Restricted Treasury Shares as Long-Term Executive Incentive

Suzuken Co ( ($JP:9987) ) just unveiled an announcement. Suzuken has approved the disposal of 36,366 treasury shares...

4M ago

Suzuken upgraded to Buy from Hold at Jefferies

Jefferies upgraded Suzuken to Buy from Hold with a price target of 5,900 yen, up from 5,200 yen....

2y ago

Suzuken downgraded to Neutral from Buy at Citi

Citi downgraded Suzuken to Neutral from Buy with a price target of 5,200 yen, up from 4,800 yen....

3y ago

SZUKF

9987 FAQ

What was Suzuken Co Ltd’s price range in the past 12 months?

Suzuken Co Ltd lowest stock price was ¥2385.00 and its highest was ¥3334.00 in the past 12 months.

What is Suzuken Co Ltd’s market cap?

Suzuken Co Ltd’s market cap is ¥335.22B.

When is Suzuken Co Ltd’s upcoming earnings report date?

Suzuken Co Ltd’s upcoming earnings report date is Nov 06, 2026 which is in 25 days.

How were Suzuken Co Ltd’s earnings last quarter?

Suzuken Co Ltd released its earnings results on Aug 07, 2026. The company reported ¥24.995 earnings per share for the quarter, missing the consensus estimate of ¥35.841 by -¥10.846.

Is Suzuken Co Ltd overvalued?

According to Wall Street analysts Suzuken Co Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Suzuken Co Ltd pay dividends?

Suzuken Co Ltd pays a Semiannually dividend of ¥30 which represents an annual dividend yield of 4.23%. See more information on Suzuken Co Ltd dividends here

What is Suzuken Co Ltd’s EPS estimate?

Suzuken Co Ltd’s EPS estimate is 43.13.

How many shares outstanding does Suzuken Co Ltd have?

Suzuken Co Ltd has 144,334,410 shares outstanding.

What happened to Suzuken Co Ltd’s price movement after its last earnings report?

Suzuken Co Ltd reported an EPS of ¥24.995 in its last earnings report, missing expectations of ¥35.841. Following the earnings report the stock price went down -0.937%.

Which hedge fund is a major shareholder of Suzuken Co Ltd?

Currently, no hedge funds are holding shares in JP:9987

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Suzuken Co Ltd

Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a wholesale distributor of pharmaceuticals, serving both domestic and international markets. The company's diverse activities are organized into four distinct divisions. Its Pharmaceutical Distribution Business focuses on sourcing a wide array of products, including ethical drugs, diagnostic reagents, medical devices, and other health-related items directly from manufacturers, and then supplying these to healthcare institutions and pharmacies. The Pharmaceutical Manufacturing Business is dedicated to the research, development, production, and commercialization of prescription pharmaceuticals and diagnostic tools, with a particular emphasis on diabetes and kidney-related conditions. Through its Pharmacy Business segment, Suzuken offers services via family pharmacists, works to enhance the efficiency of local pharmacy operations, and provides educational support. The Healthcare-Related Services Business encompasses a variety of support functions, such as contract distribution for manufacturers, the distribution of orphan drugs, and nursing care services. This segment is also involved in the development, manufacturing, and sale of medical equipment, including electrocardiographs, blood pressure monitors, stethoscopes, general medical supplies, and health promotion devices. Furthermore, Suzuken Co., Ltd. publishes medical journals for healthcare professionals and collaborates with Bushu Pharmaceuticals Ltd. to provide specialized contract drug services. The company was established in 1932 and is headquartered in Nagoya, Japan.

Suzuken Co (9987) Earnings & Revenues

Historic Earnings Reports

9987 Stock 12 Month Forecast

Average Price Target

¥6,250.00

▲(21.41% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2403":"¥2,403","4852":"¥4,852","7301":"¥7,301","3627.5":"¥3,627.5","6076.5":"¥6,076.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥7K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6250,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥6K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥5.20K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2403,3627.5,4852,6076.5,7301],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2615,2975.3846153846152,3335.7692307692305,3696.153846153846,4056.5384615384614,4416.923076923076,4777.307692307692,5137.692307692308,5498.076923076923,5858.461538461538,6218.846153846153,6579.2307692307695,6939.615384615385,{"y":7300,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2615,2894.6153846153848,3174.2307692307695,3453.846153846154,3733.4615384615386,4013.0769230769233,4292.692307692308,4572.307692307692,4851.923076923077,5131.538461538462,5411.153846153847,5690.7692307692305,5970.384615384615,{"y":6250,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2615,2813.846153846154,3012.6923076923076,3211.5384615384614,3410.3846153846152,3609.230769230769,3808.076923076923,4006.923076923077,4205.7692307692305,4404.615384615385,4603.461538461538,4802.307692307692,5001.153846153846,{"y":5200,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2852.057,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2870.195,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2933.923,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3005.494,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3055.005,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3227.56,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3020.369,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2717.343,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2532.957,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2404.431,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2516.645,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2585.851,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2615,"date":1790812800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >